214 related articles for article (PubMed ID: 9746591)
61. Protective efficacy of recombinant canine adenovirus type-2 expressing TgROP18 (CAV-2-ROP18) against acute and chronic Toxoplasma gondii infection in mice.
Li XZ; Wang XH; Xia LJ; Weng YB; Hernandez JA; Tu LQ; Li LT; Li SJ; Yuan ZG
BMC Infect Dis; 2015 Mar; 15():114. PubMed ID: 25886737
[TBL] [Abstract][Full Text] [Related]
62. Toxoplasma gondii: DNA vaccination with genes encoding antigens MIC2, M2AP, AMA1 and BAG1 and evaluation of their immunogenic potential.
Dautu G; Munyaka B; Carmen G; Zhang G; Omata Y; Xuenan X; Igarashi M
Exp Parasitol; 2007 Jul; 116(3):273-82. PubMed ID: 17379212
[TBL] [Abstract][Full Text] [Related]
63. Comparison of cholera toxin A2/B and murine interleukin-12 as adjuvants of Toxoplasma multi-antigenic SAG1-ROP2 DNA vaccine.
Xue M; He S; Zhang J; Cui Y; Yao Y; Wang H
Exp Parasitol; 2008 Jul; 119(3):352-7. PubMed ID: 18442818
[TBL] [Abstract][Full Text] [Related]
64. Toxoplasma gondii antigens recognized by IgG antibodies differ between mice with and without active proliferation of tachyzoites in the brain during the chronic stage of infection.
Hester J; Mullins J; Sa Q; Payne L; Mercier C; Cesbron-Delauw MF; Suzuki Y
Infect Immun; 2012 Oct; 80(10):3611-20. PubMed ID: 22851753
[TBL] [Abstract][Full Text] [Related]
65. Application and expression of Toxoplasma gondii surface antigen 2 (SAG2) and rhoptry protein 2 (ROP2) from recombinant Escherichia coli strain.
Yan H; Yan H; Tao Y; Chen H; Li G; Gong W; Jiao H; Tian F; Ji M
Trans R Soc Trop Med Hyg; 2012 Jun; 106(6):356-62. PubMed ID: 22537565
[TBL] [Abstract][Full Text] [Related]
66. A combination of antigenic regions of Toxoplasma gondii microneme proteins induces protective immunity against oral infection with parasite cysts.
Beghetto E; Nielsen HV; Del Porto P; Buffolano W; Guglietta S; Felici F; Petersen E; Gargano N
J Infect Dis; 2005 Feb; 191(4):637-45. PubMed ID: 15655789
[TBL] [Abstract][Full Text] [Related]
67. Immunological response of sheep to injections of plasmids encoding Toxoplasma gondii SAG1 and ROP1 genes.
Li B; Oledzka G; McFarlane RG; Spellerberg MB; Smith SM; Gelder FB; Kur J; Stankiewicz M
Parasite Immunol; 2010; 32(9-10):671-83. PubMed ID: 20691019
[TBL] [Abstract][Full Text] [Related]
68. Immunological responses induced by a DNA vaccine expressing RON4 and by immunogenic recombinant protein RON4 failed to protect mice against chronic toxoplasmosis.
Rashid I; Hedhli D; Moiré N; Pierre J; Debierre-Grockiego F; Dimier-Poisson I; Mévélec MN
Vaccine; 2011 Nov; 29(48):8838-46. PubMed ID: 21983362
[TBL] [Abstract][Full Text] [Related]
69. A purified parasite antigen (p30) mediates CD8+ T cell immunity against fatal Toxoplasma gondii infection in mice.
Khan IA; Ely KH; Kasper LH
J Immunol; 1991 Nov; 147(10):3501-6. PubMed ID: 1940350
[TBL] [Abstract][Full Text] [Related]
70. [Studies on the immuno-protection of ROP2 nuclei acid vaccine in Toxoplasma gondii infection].
Wei QK; Li J; Fu TX; Bai XL; Cui Y; Zhang DB; Wang HF; Liu YB; Fu B; Zai DF; Huang BC; Liu KY; Han GD
Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 2006 Oct; 24(5):337-41. PubMed ID: 17361811
[TBL] [Abstract][Full Text] [Related]
71. Toxoplasma gondii: Vaccination with a DNA vaccine encoding T- and B-cell epitopes of SAG1, GRA2, GRA7 and ROP16 elicits protection against acute toxoplasmosis in mice.
Cao A; Liu Y; Wang J; Li X; Wang S; Zhao Q; Cong H; He S; Zhou H
Vaccine; 2015 Nov; 33(48):6757-62. PubMed ID: 26518401
[TBL] [Abstract][Full Text] [Related]
72. Toxoplasma gondii: protective effect of an intranasal SAG1 and MIC4 DNA vaccine in mice.
Wang H; He S; Yao Y; Cong H; Zhao H; Li T; Zhu XQ
Exp Parasitol; 2009 Jul; 122(3):226-32. PubMed ID: 19366622
[TBL] [Abstract][Full Text] [Related]
73. Protective effect of DNA-mediated immunization with a combination of SAG1 and IL-2 gene adjuvant against infection of Toxoplasma gondii in mice.
Chen G; Chen H; Guo H; Zheng H
Chin Med J (Engl); 2002 Oct; 115(10):1448-52. PubMed ID: 12490084
[TBL] [Abstract][Full Text] [Related]
74. Combination of CpG-oligodeoxynucleotides with recombinant ROP2 or GRA4 proteins induces protective immunity against Toxoplasma gondii infection.
Sánchez VR; Pitkowski MN; Fernández Cuppari AV; Rodríguez FM; Fenoy IM; Frank FM; Goldman A; Corral RS; Martin V
Exp Parasitol; 2011 Aug; 128(4):448-53. PubMed ID: 21554876
[TBL] [Abstract][Full Text] [Related]
75. Protective immunity against Toxoplasma challenge in mice by coadministration of T. gondii antigens and Eimeria profilin-like protein as an adjuvant.
Hedhli D; Dimier-Poisson I; Judge JW; Rosenberg B; Mévélec MN
Vaccine; 2009 Apr; 27(16):2274-81. PubMed ID: 19428842
[TBL] [Abstract][Full Text] [Related]
76. Protective effect of vaccination with a combination of recombinant surface antigen 1 and interleukin-12 against toxoplasmosis in mice.
Letscher-Bru V; Villard O; Risse B; Zauke M; Klein JP; Kien TT
Infect Immun; 1998 Sep; 66(9):4503-6. PubMed ID: 9712808
[TBL] [Abstract][Full Text] [Related]
77. Evaluation of protective effect of DNA vaccination with genes encoding antigens GRA4 and SAG1 associated with GM-CSF plasmid, against acute, chronical and congenital toxoplasmosis in mice.
Mévélec MN; Bout D; Desolme B; Marchand H; Magné R; Bruneel O; Buzoni-Gatel D
Vaccine; 2005 Aug; 23(36):4489-99. PubMed ID: 15935521
[TBL] [Abstract][Full Text] [Related]
78. Evaluation of protective effect of recombinant dense granule antigens GRA2 and GRA6 formulated in monophosphoryl lipid A (MPL) adjuvant against Toxoplasma chronic infection in mice.
Golkar M; Shokrgozar MA; Rafati S; Musset K; Assmar M; Sadaie R; Cesbron-Delauw MF; Mercier C
Vaccine; 2007 May; 25(21):4301-11. PubMed ID: 17418457
[TBL] [Abstract][Full Text] [Related]
79. Protective immune response against Toxoplasma gondii elicited by a novel yeast-based vaccine with microneme protein 16.
Wang LJ; Xiao T; Xu C; Li J; Liu GZ; Yin K; Cui Y; Wei QK; Huang BC; Sun H
Vaccine; 2018 Jun; 36(27):3943-3948. PubMed ID: 29793893
[TBL] [Abstract][Full Text] [Related]
80. Targeted Delivery of
Lakhrif Z; Moreau A; Hérault B; Di-Tommaso A; Juste M; Moiré N; Dimier-Poisson I; Mévélec MN; Aubrey N
Front Immunol; 2018; 9():317. PubMed ID: 29515595
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
